The first FDA device advisory panel to address a product on FDA’s breakthrough pathway overwhelmingly recommended approval of the novel heart-failure device. The recommendation came despite panel uncertainty during a Dec. 4 meeting as to whether there was enough trial data to prove safety and effectiveness.
Members of FDA’s Circulatory System Devices panel voted 12-1 that Impulse Dynamics NV’s Optimizer Smart System is safe; 11-2...